Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Schizophrenia Spectrum Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07005245
What this trial is testing

Survey on the Reproductive and Child-Rearing Situations of Patients With Severe Mental Disorders

Who this might be right for
Schizophrenia and Schizoaffective DisorderBipolar Disorder (BD)
Peking University 77,145
Not applicableUnknownNCT02479919
What this trial is testing

Treating Social Cognition With Theta Burst Stimulation: a Multicentric Study

Who this might be right for
Social Cognition in Patients With Schizophrenia
University Hospital, Caen 61
Large-scale testing (Phase 3)UnknownNCT00315081
What this trial is testing

Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine

Who this might be right for
SchizophreniaHyperprolactinemia
University Hospital, Bonn 20
Not applicableEnded earlyNCT03069612
What this trial is testing

RTMS Treatment for Cannabis Use Disorders in Psychosis

Who this might be right for
Cannabis Use DisorderPsychosis
Centre for Addiction and Mental Health 4
Not applicableStudy completedNCT03280810
What this trial is testing

Effects of a Psycho-corporal Training on Postural and Cognitive Dual-task Performances in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Centre Hospitalier Universitaire de Saint Etienne 30
Large-scale testing (Phase 3)Study completedNCT00640510
What this trial is testing

A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With Schizophrenia

Who this might be right for
Schizophrenia
Eli Lilly and Company 34
Large-scale testing (Phase 3)Study completedNCT03043820
What this trial is testing

Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+1 more
Iris Sommer 110
Not applicableWithdrawnNCT03407950
What this trial is testing

Cognitive Remediation Program for Hospitalized in the Long Term Patients With Deficit Schizophrenia

Who this might be right for
Schizophrenia
University Hospital, Montpellier
Not applicableLooking for participantsNCT07647380
What this trial is testing

TIS for Improving Cognitive Impairment in Schizophrenia

Who this might be right for
Schizophrenia DisorderCognitive Impairments
Central South University 50
Large-scale testing (Phase 3)Study completedNCT00088491
What this trial is testing

Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With Schizophrenia

Who this might be right for
Schizophrenic Disorders
Eli Lilly and Company 1,205
Not applicableStudy completedNCT03055520
What this trial is testing

Arithmetic Training With the Kumon Method for Cognition in Schizophrenia

Who this might be right for
Schizophrenia
University of Sao Paulo 51
Post-approval studies (Phase 4)Study completedNCT00313391
What this trial is testing

Risperdal Consta and Health Care Utilization in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Emory University
Not applicableStudy completedNCT05633108
What this trial is testing

A Study Based on the French National Health Insurance Database in Participants With Psychotic Disorders

Who this might be right for
Psychotic Disorders
Eisai Co., Ltd. 579,728
Early research (Phase 1)Study completedNCT03164876
What this trial is testing

Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers.

Who this might be right for
Schizophrenia
Autifony Therapeutics Limited 24
Large-scale testing (Phase 3)Study completedNCT01448720
What this trial is testing

Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate

Who this might be right for
Schizophrenia
Janssen-Cilag Farmaceutica Ltda. 142
Post-approval studies (Phase 4)Study completedNCT00864825
What this trial is testing

Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Sheba Medical Center 248
Large-scale testing (Phase 3)Study completedNCT00111189
What this trial is testing

The Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 414
Early research (Phase 1)Study completedNCT02392468
What this trial is testing

Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers

Who this might be right for
SchizophreniaAlzheimer Disease
Boehringer Ingelheim 61
Early research (Phase 1)Study completedNCT00892125
What this trial is testing

The Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in Patients With Schizophrenia or Bipolar I Disorder

Who this might be right for
SchizophreniaBipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 64
Not applicableStudy completedNCT02565524
What this trial is testing

The Phenotypic and Genetic Profile of Patients With Early Onset Schizophrenia Associated With Autism Spectrum Disorder.

Who this might be right for
SchizophreniaDissociative Disorders
Fondation Lenval 111
Next Page